References
1. Cabanillas B, Akdis CA, Novak N. Allergic reactions to the first
COVID-19 vaccine: A potential role of polyethylene glycol?Allergy . 2021;76:1617-1618. doi: 10.1111/all.14711.
2. Klimek L, Novak N, Cabanillas B, Jutel M, Bousquet J, Akdis CA.
Allergenic components of the mRNA-1273 vaccine for COVID-19: Possible
involvement of polyethylene glycol and IgG-mediated complement
activation. Allergy . 2021 Mar 3:10.1111/all.14794. doi:
10.1111/all.14794.
3. Sokolowska M, Eiwegger T, Ollert M, et al. EAACI statement on the
diagnosis, management and prevention of severe allergic reactions to
COVID-19 vaccines. Allergy . 2021;76:1629-1639. doi:
10.1111/all.14739.
4. Greenhawt M, Abrams EM, Shaker M, et al. The Risk of Allergic
Reaction to SARS-CoV-2 Vaccines and Recommended Evaluation and
Management: A Systematic Review, Meta-Analysis, GRADE Assessment, and
International Consensus Approach. J Allergy Clin Immunol Pract .
2021 Jun 18:S2213-2198(21)00671-1. doi: 10.1016/j.jaip.2021.06.006.
5. Troelnikov A, Perkins G, Yuson C, Ahamdie A, Balouch S, Hurtado PR,
Hissaria P. Basophil reactivity to BNT162b2 is mediated by PEGylated
lipid nanoparticles in patients with PEG allergy. J Allergy Clin
Immunol . 2021;148:91-95. doi: 10.1016/j.jaci.2021.04.032. Epub 2021 May
12. PMID: 33991580.
6. Warren CM, Snow TT, Lee AS, et al. Assessment of Allergic and
Anaphylactic Reactions to mRNA COVID-19 Vaccines With Confirmatory
Testing in a US Regional Health System. JAMA Netw Open .
2021;4:e2125524. doi: 10.1001/jamanetworkopen.2021.25524.
7. Elieh Ali Komi D, Shafaghat F, Kovanen PT, Meri S. Mast cells and
complement system: Ancient interactions between components of innate
immunity. Allergy . 2020;75:2818-2828. doi: 10.1111/all.14413
8. Risma KA, Edwards KM, Hummell DS,et a. Potential mechanisms of
anaphylaxis to COVID-19 mRNA vaccines. J Allergy Clin Immunol .
2021;147:2075-2082.e2. doi: 10.1016/j.jaci.2021.04.002.